CLINICAL_TRIALS
trial_result
· 2012-12-06
Clinical Trial Update: A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC) [Phase 4]
Summary
Phase 4 clinical trial evaluating leukocytapheresis for ulcerative colitis was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Asahi Kasei Medical Co., Ltd. | Conditions: Ulcerative Colitis | Phase 4 | Status: TERMINATED